GLANCE STOCKS NEWS EUROPE-Astra up in weak pharma after Citi support

STOCKS NEWS Reuters Results diary Stocks on the move Real-time Equity News 08:45GMT 09Oct2008-Astra up in weak pharma after Citi support AstraZeneca shares are up 1.8 percent after Citi raises share price target to 27 pounds from 25.82 but European pharma stocks overall retreat as investors switch funds out of the defensive sector in a stronger stock market. GlaxoSmithKline falls 1.9 percent, Novartis 1.7 percent and Roche 1 percent. Citi says results next month from the Jupiter study of AstraZeneca's cholesterol drug Crestor should be good news. It forecasts global 2012 Crestor sales of $6.8 billion versus consensus of $5.6 billion. AstraZeneca CEO David Brennan told Reuters last month Jupiter would be 'very important'. For more double click on Reuters Messaging rm://ben.hirschler.reuters.com@reuters.net... [read full story]